Calmodulin as a Potential Target by Which Berberine Induces Cell Cycle Arrest in Human Hepatoma Bel7402 Cells
Version of Record online: 25 MAY 2013
© 2013 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 81, Issue 6, pages 775–783, June 2013
How to Cite
Ma, C., Tang, K., Liu, Q., Zhu, R. and Cao, Z. (2013), Calmodulin as a Potential Target by Which Berberine Induces Cell Cycle Arrest in Human Hepatoma Bel7402 Cells. Chemical Biology & Drug Design, 81: 775–783. doi: 10.1111/cbdd.12124
- Issue online: 25 MAY 2013
- Version of Record online: 25 MAY 2013
- Accepted manuscript online: 19 FEB 2013 11:25PM EST
- Manuscript Accepted: 9 FEB 2013
- Manuscript Revised: 5 JAN 2013
- Manuscript Received: 22 OCT 2012
- Ministry of Science and Technology China. Grant Numbers: 2010CB833601, 2012ZX10005001, 2012AA020404
- National Natural Science Foundation of China. Grant Numbers: 31200986, 30900832, and 30973611
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.